We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

50Q:FWBYandal Resources Ltd. Analysis

Data as of 2026-05-14 - not real-time

€0.13

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yandal Resources trades at €0.126, sitting just below its 200‑day SMA (0.1268) but slightly above the 20‑day SMA (0.1219), indicating a modest short‑term upside bias. The RSI of 53 and a bullish MACD histogram (0.00057) suggest momentum is mildly positive, yet the overall trend remains neutral and price is trapped between a support of €0.106 and resistance of €0.131. Volatility is extremely high at 92.8% over the past 30 days and beta is low at 0.61, highlighting a stock that can swing sharply while being less correlated with broader market moves. Fundamentally the company shows strong revenue growth (≈38%) but severe profitability issues – operating margin is –55% and net profit margin –180%, with negative EBITDA and cash‑flow deficits despite a solid cash balance of €17.3 M and minimal debt (€0.16 M). Valuation multiples are stretched: price‑to‑book sits at 4.27× and price‑to‑sales at 12.27×, far above typical gold‑sector averages, reinforcing an overvalued picture. The lack of any dividend and negative earnings further diminish the case for income‑focused investors, while the speculative upside hinges on successful gold exploration in Western Australia.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • high valuation multiples (P/B 4.27, P/S 12.27)
  • negative operating cash flow and earnings
  • elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong cash position versus minimal debt
  • potential upside from gold exploration projects
  • persistent earnings deficits and overvaluation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • exposure to gold price appreciation
  • large untapped resource base in Western Australia
  • low debt and ample cash providing a financial cushion

Key Metrics & Analysis

Financial Health

Revenue Growth3755.80%
Profit Margin-180.23%
ROE-51.77%
ROA-29.68%
Debt/Equity0.91
P/B Ratio4.3
Op. Cash Flow€-10122864
Free Cash Flow€-4861094

Technical Analysis

TrendNeutral
RSI53.3
Support€0.11
Resistance€0.13
MA 20€0.12
MA 50€0.12
MA 200€0.13
MACDBullish
VolumeStable
Fear & Greed Index89.59

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.61
Volatility92.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.